News

Hosted on MSN11mon
Why Dyne Therapeutics, With A 166% Run This Year, Just Catapulted Again
Top-notch biotech stock Dyne Therapeutics broke out Monday after the company unveiled promising test results for a pair of muscular dystrophy treatments. Please watch the video at Investors.com ...
Business Insider11d
Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments
WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with ...
Business Insider1mon
Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), Quest Diagnostics (DGX) and Belite Bio, Inc. ADR (BLTE)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dyne Therapeutics (DYN – Research Report), Quest Diagnostics (DGX – Research Report) and Belite Bio, ...
manilatimes1mon
Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer
WALTHAM, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with ...